HRS-7450 / Jiangsu Hengrui Pharma - LARVOL DELTA

HRS-7450-201: HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke. (clinicaltrials.gov) - P2 | N=208 | Not yet recruiting | Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

New P2 trial • Cardiovascular • Ischemic stroke

HRS-7450-201: HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke. (clinicaltrials.gov) - P2 | N=208 | Recruiting | Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Ischemic stroke

HRS-7450-102: Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical Trial (clinicaltrials.gov) - P1 | N=64 | Completed | Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed

Trial completion • Cardiovascular • Ischemic stroke

HRS-7450-102: Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical Trial (clinicaltrials.gov) - P1 | N=63 | Active, not recruiting | Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Recruiting ➔ Active, not recruiting

Enrollment closed • Cardiovascular • Ischemic stroke

HRS-7450-102: Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical Trial (clinicaltrials.gov) - P1 | N=62 | Recruiting | Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Cardiovascular • Ischemic stroke

Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical Trial (clinicaltrials.gov) - P1 | N=62 | Not yet recruiting | Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

New P1 trial • Cardiovascular • Ischemic stroke

A Trial of HRS-7450 in Chinese Healthy Volunteers (clinicaltrials.gov) - P1 | N=50 | Not yet recruiting | Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

New P1 trial • Cardiovascular